Reproductive history and risk of colorectal cancer in postmenopausal women

Journal of the National Cancer Institute

Volumn 103, Issue 10, 2011, Pages 826-834

  Zervoudakis, Alice ^a,b   Strickler, Howard D ^b   Park, Yikyung ^c   Xue, Xiaonan ^b   Hollenbeck, Albert ^d   Schatzkin, Arthur ^c   Gunter, Marc J ^b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d AARP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; SEX HORMONE;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; COHORT ANALYSIS; COLORECTAL CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENARCHE; MENOPAUSE; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; REPRODUCTION;

AGE FACTORS; AGED; COLORECTAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MENARCHE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PARTURITION; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; REPRODUCTIVE HISTORY; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 79957508112     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr101     Document Type: Article

References (56)

1. American Cancer Society. Cancer Facts and Figures 2010. http://www5.cancer.org/downloads/STT/Cancer-Facts-and-Figures-2010.pdf.
2. McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: A review and hypothesis. J Natl Cancer Inst. 1980;65(6):1201-1207. (Pubitemid 11196006)
3. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis. Am J Med. 1999;106(5):574-582. (Pubitemid 29231110)
4. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004;350(10):991-1004. (Pubitemid 38269276)
5. Ritenbaugh C, Stanford JL, Wu L, et al. Conjugated equine estrogens and colorectal cancer incidence and survival: The Women's Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2609-2618.
6. Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res. 2008;68(1):329-337. (Pubitemid 351380136)
7. Clendenen TV, Koenig KL, Shore RE, et al. Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(1):275-281.
8. Narayan S, Rajakumar G, Prouix H, et al. Estradiol is trophic for colon cancer in mice: Effect on ornithine decarboxylase and c-myc messenger RNA. Gastroenterology. 1992;103(6):1823-1832.
9. Singh S, Paraskeva C, Gallimore PH, et al. Differential growth response to oestrogen of premalignant and malignant colonic cell lines. Anticancer Res. 1994;14(3A):1037-1041. (Pubitemid 24272564)
10. Di Domenico M, Castoria G, Bilancio A, et al. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res. 1996;56(19):4516-4521. (Pubitemid 26330464)
11. Hennessy BA, Harvey BJ, Healy V. 17beta-Estradiol rapidly stimulates c-fos expression via the MAPK pathway in T84 cells. Mol Cell Endocrinol. 2005;229(1-2):39-47. (Pubitemid 40018081)
12. Hankinson SE, Colditz GA, Hunter DJ, et al. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States). Cancer Causes Control. 1995;6(3):217-224.
13. Chubak J, Tworoger SS, Yasui Y, et al. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev. 2004;13(8):1296-1301. (Pubitemid 39071552)
14. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15(1):36-47. (Pubitemid 23269069)
15. Chavez-MacGregor M, Elias SG, Onland-Moret NC, et al. Postmenopausal breast cancer risk and cumulative number of menstrual cycles. Cancer Epidemiol Biomarkers Prev. 2005;14(4):799-804. (Pubitemid 40478538)
16. Dossus L, Allen N, Kaaks R, et al. Reproductive risk factors and endome-trial cancer: The European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2009;127(2):442-451.
17. Kabat GC, Miller AB, Rohan TE. Oral contraceptive use, hormone re-placement therapy, reproductive history and risk of colorectal cancer in women. Int J Cancer. 2008;122(3):643-646. (Pubitemid 350308959)
18. Lin J, Zhang SM, Cook NR, et al. Oral contraceptives, reproductive fac-tors, and risk of colorectal cancer among women in a prospective cohort study. Am J Epidemiol. 2007;165(7):794-801. (Pubitemid 46434606)
19. Martinez ME, Grodstein F, Giovannucci E, et al. A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(1):1-5. (Pubitemid 27030419)
20. Akhter M, Inoue M, Kurahashi N, et al. Reproductive factors, exogenous female hormone use and colorectal cancer risk: The Japan Public Health Center-based Prospective Study. Eur J Cancer Prev. 2008;17(6):515-524.
21. Tamakoshi K, Wakai K, Kojima M, et al. A prospective study of reproduc-tive and menstrual factors and colon cancer risk in Japanese women: Findings from the JACC study. Cancer Sci. 2004;95(7):602-607. (Pubitemid 39089643)
22. Kvale G, Heuch I. Is the incidence of colorectal cancer related to repro-duction? A prospective study of 63,000 women. Int J Cancer. 1991;47(3):390-395.
23. Kravdal O, Glattre E, Kvale G, et al. A sub-site-specific analysis of the relationship between colorectal cancer and parity in complete male and female Norwegian birth cohorts. Int J Cancer. 1993;53(1):56-61. (Pubitemid 23018423)
24. Fernandez E, La Vecchia C, Balducci A, et al. Oral contraceptives and colorectal cancer risk: A meta-analysis. Br J Cancer. 2001;84(5):722-727. (Pubitemid 32239011)
25. Tsilidis KK, Allen NE, Key TJ, et al. Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer. 2010;103(11):1755-1759.
26. Kronenberg HM. Williams Textbook of Endocrinology. 11th ed. Philadelphia, PA: Saunders; 2007.
27. Schatzkin A, Subar AF, Thompson FE, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: The National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol. 2001;154(12):1119-1125. (Pubitemid 33140635)
28. North American Association of Central Cancer Registries (NAACCR). Standards for Completeness, Quality, Analysis and Management of Data. http://www.naaccr.org/StandardsandRegistryOperations/VolumeIII.aspx.
29. Michaud DS, Midthune D, Hermansen S, et al. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Reg Manag. 2005;32(2):70-75.
30. World Health Organization. International Classification of Diseases for Oncology (ICD-O). 3rd ed. Geneva, Switzerland: CAP Press and Publications; 2000.
31. World Health Organization. BMI Classification. http://apps.who.int/bmi/ index.jsp?introPage=intro-3.html. Accessed September, 2010.
32. Lacey JV Jr, Kreimer AR, Buys SS, et al. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer. Mar 17;9:84.
33. Winter DC, Taylor C, Cosullivan G, et al. Mitogenic effects of oestro-gen mediated by a non-genomic receptor in human colon. Br J Surg. 2000;87(12):1684-1689.
34. Oduwole OO, Isomaa VV, Nokelainen PA, et al. Downregulation of estrogen-metabolizing 17 beta-hydroxysteroid dehydrogenase type 2 ex-pression correlates inversely with Ki67 proliferation marker in colon-cancer development. Int J Cancer. 2002;97(1):1-6.
35. English MA, Kane KF, Cruickshank N, et al. Loss of estrogen inactivation in colonic cancer. J Clin Endocrinol Metab. 1999;84(6):2080-2085. (Pubitemid 30647037)
36. Sato R, Suzuki T, Katayose Y, et al. Steroid sulfatase and estrogen sulfo-transferase in colon carcinoma: Regulators of intratumoral estrogen con-centrations and potent prognostic factors. Cancer Res. 2009;69(3):914-922.
37. Grivas PD, Tzelepi V, Sotiropoulou-Bonikou G, et al. Expression of ERalpha, ERbeta and co-regulator PELP1/MNAR in colorectal cancer: Prognostic significance and clinicopathologic correlations. Cell Oncol. 2009;31(3):235-247.
38. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001;2(3):133-140. (Pubitemid 33585924)
39. Apter D, Reinila M, Vihko R. Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer. 1989;44(5):783-787. (Pubitemid 20007972)
40. MacMahon B, Trichopoulos D, Brown J, et al. Age at menarche, urine estrogens and breast cancer risk. Int J Cancer. 1982;30(4):427-431. (Pubitemid 12003728)
41. Trichopoulos D, Brown J, MacMahon B. Urine estrogens and breast cancer risk factors among post-menopausal women. Int J Cancer. 1987;40(6):721-725. (Pubitemid 18003866)
42. Russo J, Russo IH. Differentiation and breast cancer. Medicina (B Aires). 1997;57(suppl 2):81-91. (Pubitemid 127510501)
43. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat. 1982;2(1):5-73. (Pubitemid 12017450)
44. Oshima CT, Wonraht DR, Catarino RM, et al. Estrogen and progester-one receptors in gastric and colorectal cancer. Hepatogastroenterology. 1999;46(30):3155-3158.
45. Hendrickse CW, Jones CE, Donovan IA, et al. Oestrogen and progester-one receptors in colorectal cancer and human colonic cancer cell lines. Br J Surg. 1993;80(5):636-640. (Pubitemid 23167253)
46. Singh S, Sheppard MC, Langman MJ. Sex differences in the incidence of colorectal cancer: An exploration of oestrogen and progesterone receptors. Gut. 1993;34(5):611-615. (Pubitemid 23146883)
47. Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and trans-dermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 1991;72(2):374-381. (Pubitemid 21921702)
48. Campagnoli C, Abba C, Ambroggio S, et al. Differential effects of proges-tins on the circulating IGF-I system. Maturitas. 2003;46(suppl 1):S39-S44. (Pubitemid 37506061)
49. Raudaskoski T, Laatikainen T, Kauppila A. Sex-hormone binding glob-ulin as an indicator of the hepatic impacts of continuous combined hormone replacement regimens. Maturitas. 1998;29(1):87-92. (Pubitemid 28247572)
50. Key TJ, Appleby PN, Reeves GK, et al. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: Pooled individual data analysis of 17 prospective studies. Lancet Oncol. 11(6):530-542.
51. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2007).: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2010.
52. Kvale G, Heuch I. A prospective study of reproductive factors and breast cancer. II. Age at first and last birth. Am J Epidemiol. 1987;126(5):842-850. (Pubitemid 17161308)
53. Trichopoulos D, Hsieh CC, MacMahon B, et al. Age at any birth and breast cancer risk. Int J Cancer. 1983;31(6):701-704. (Pubitemid 13060771)
54. Stuebe AM, Willett WC, Xue F, et al. Lactation and incidence of premen-opausal breast cancer: A longitudinal study. Arch Intern Med. 2009;169(15):1364-1371.
55. Howe HL, Senie RT, Bzduch H, et al. Early abortion and breast cancer risk among women under age 40. Int J Epidemiol. 1989;18(2):300-304. (Pubitemid 19188014)
56. Ewertz M, Duffy SW. Risk of breast cancer in relation to reproductive factors in Denmark. Br J Cancer. 1988;58(1):99-104.